Apoglyx Competitors and Similar CompaniesClear all
Apoglyx's competitors and similar companies include Carmot Therapeutics and Viking Therapeutics.
 Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. |  Viking Therapeutics Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders. | |
Founding Date | Founding Date 2015 | Founding Date 2008 | Founding Date 2012 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Malmö, SE HQ Lund, SE | Locations Berkeley, US HQ | Locations San Diego, US HQ |
Employees | Employees 525% increase | Employees 109% decrease | Employees 2729% increase |
Financial | |||
Net income | Net income N/A | Net income ($38.8m) (FY, 2022) | Net income ($359.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 74.8m | Total funding raised $ 15m |
For sources of this data, please see the company profile
View Company Profiles
Carmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View companyViking Therapeutics
HQ
San Diego, US
Employees
27↑ 29% increase
Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.
View company